The "Glucose Goddess" built a brand around her blood sugar balancing hacks. She said a few simple swaps to her diet boosted ...

The use of CGM has been growing among people without diabetes, including those with prediabetes, particularly with the ...

Continuous glucose monitors — the tiny sensors once reserved for people with diabetes — are now appearing on the arms of ...

Analysts have set 12-month price targets for DexCom, revealing an average target of $97.15, a high estimate of $106.00, and a ...

The devices have surged in popularity among people without diabetes, but a study suggests reality may not match the hype.View on euronews ...

Experts weigh in on the most promising AI applications, from diabetic retinopathy screening to smarter insulin delivery, and ...

Dexcom is facing scrutiny and class-action lawsuits over alleged safety and accuracy issues with its G7 monitor.

The company's CEO, Tom Hale, told MobiHealthNews Oura will use the funds "for AI-driven innovation to redefine what digital ...

Spending more time in glucose range could help reduce adverse pregnancy outcomes, but available closed-loop insulin delivery systems are not customized to pregnancy-specific needs. In a randomized ...

Health Panels follows the lead of competitors by offering blood tests that users can schedule and review within the Oura app.

Research shows that more daytime movement in pregnant women with hyperglycemia can raise nighttime blood sugar, highlighting ...

The Flinn Foundation recently released the latest version of its Bioscience Roadmap for Arizona — a guide to the sector in ...